A Novel Cognitive Enhancing Drug for Borderline Personality Disorder

Condition:   Borderline Personality DisorderInterventions:   Drug: NMDA receptor antagonist (active drug);   Other: Lactose packed capsule (inert/inactive arm)Sponsor:   The AlfredNot yet recruiting - verified July 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials